Valmark Advisers Inc. Makes New Investment in Cardinal Health, Inc. $CAH

Key Points

• Valmark Advisers Inc. has acquired a new position in Cardinal Health, Inc., purchasing 1,679 shares valued at approximately $282,000 during Q2.
• Insider transactions revealed significant sales, with CEO Stephen M. Mason and insider Jessica L. Mayer selling a combined total of 79,653 shares, reflecting large decreases in their respective holdings.
• Analysts generally maintain a positive outlook for Cardinal Health, with an average rating of "Moderate Buy" and a price target of $166.00, despite some recent downgrades by brokerages.

Valmark Advisers Inc. bought a new position in Cardinal Health, Inc. (NYSE:CAH - Free Report) during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor bought 1,679 shares of the company's stock, valued at approximately $282,000.

Several other institutional investors and hedge funds have also bought and sold shares of the company. JPMorgan Chase & Co. lifted its stake in Cardinal Health by 40.0% in the 1st quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company's stock worth $575,327,000 after purchasing an additional 1,193,983 shares in the last quarter. Northern Trust Corp increased its holdings in shares of Cardinal Health by 3.5% in the 1st quarter. Northern Trust Corp now owns 3,143,003 shares of the company's stock worth $433,012,000 after buying an additional 105,154 shares during the last quarter. Wellington Management Group LLP increased its holdings in shares of Cardinal Health by 1,666.7% in the 1st quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company's stock worth $328,470,000 after buying an additional 2,249,241 shares during the last quarter. Price T Rowe Associates Inc. MD increased its holdings in shares of Cardinal Health by 3.3% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 1,654,036 shares of the company's stock worth $227,877,000 after buying an additional 52,714 shares during the last quarter. Finally, Dimensional Fund Advisors LP increased its holdings in shares of Cardinal Health by 0.6% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,246,788 shares of the company's stock worth $171,749,000 after buying an additional 7,940 shares during the last quarter. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Cardinal Health

In other news, insider Jessica L. Mayer sold 38,078 shares of the firm's stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total value of $5,666,767.96. Following the completion of the sale, the insider directly owned 48,457 shares of the company's stock, valued at approximately $7,211,370.74. This trade represents a 44.00% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Stephen M. Mason sold 41,575 shares of the firm's stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $6,187,191.50. Following the completion of the sale, the chief executive officer directly owned 26,085 shares of the company's stock, valued at approximately $3,881,969.70. This represents a 61.45% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 271,676 shares of company stock worth $40,489,525. 0.12% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on CAH. Weiss Ratings reissued a "buy (b)" rating on shares of Cardinal Health in a report on Wednesday. Evercore ISI decreased their price target on shares of Cardinal Health from $200.00 to $190.00 and set an "outperform" rating on the stock in a report on Wednesday, August 13th. Wall Street Zen lowered shares of Cardinal Health from a "strong-buy" rating to a "buy" rating in a report on Saturday, August 2nd. Jefferies Financial Group set a $150.00 price target on shares of Cardinal Health in a report on Tuesday, August 12th. Finally, Morgan Stanley reaffirmed an "overweight" rating on shares of Cardinal Health in a report on Tuesday, August 12th. Twelve analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, Cardinal Health presently has an average rating of "Moderate Buy" and an average price target of $166.00.

Cardinal Health Stock Down 0.2%

Shares of Cardinal Health stock opened at $156.86 on Friday. The firm has a market cap of $37.27 billion, a PE ratio of 24.32, a price-to-earnings-growth ratio of 1.33 and a beta of 0.71. Cardinal Health, Inc. has a 12-month low of $106.98 and a 12-month high of $168.44. The company's fifty day simple moving average is $152.09 and its two-hundred day simple moving average is $151.09.

Cardinal Health (NYSE:CAH - Get Free Report) last announced its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.03 by $0.05. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The business had revenue of $60.16 billion for the quarter, compared to analyst estimates of $60.91 billion. During the same quarter last year, the firm earned $1.84 EPS. The company's revenue was up .5% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. As a group, sell-side analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be given a $0.5107 dividend. This represents a $2.04 annualized dividend and a dividend yield of 1.3%. The ex-dividend date of this dividend is Wednesday, October 1st. Cardinal Health's dividend payout ratio (DPR) is currently 31.63%.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.